Under normal conditions, IGF-I is more potent than insulin; however, in the plasma of obese patients, IGF-I was positively associated with body fat mass, while low IGF-I has been linked to obesity-related complications such as insulin resistance and type 2 diabetes mellitus [71,72]. Here, IGF1 is linked to obesity disorder.